WO1998043652A1 - Boron carbohydrate complexes and uses thereof - Google Patents
Boron carbohydrate complexes and uses thereof Download PDFInfo
- Publication number
- WO1998043652A1 WO1998043652A1 PCT/US1998/006050 US9806050W WO9843652A1 WO 1998043652 A1 WO1998043652 A1 WO 1998043652A1 US 9806050 W US9806050 W US 9806050W WO 9843652 A1 WO9843652 A1 WO 9843652A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- boron
- supplement
- carbohydrate
- food
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/325—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the field of the invention is dietary boron.
- boron is essential for the structure and function of cell walls, and may also be important in regulating hormones. In many animals, boron apparently also plays an important role, especially in calcium and magnesium metabolism. In chickens, for example, boron deficiency leads to poor growth and leg abnormalities in chicks, while boron supplementation produces 5 stronger egg shells. (Mastromatto E., et al., "Summary: International Symposium on the Health Effects of Boron and its Compounds", Environ Health Perspect., 1994 Nov.; 102, 7: 139-41).
- boron is marketed as calcium borogluconate (Now Foods, Glendale Hts., Ill), and as boron citrate, aspartame and glycinate chelates (Twin Laboratories, Inc., Ronkonkoma, NY).
- boron supplementation leave something to be desired.
- the known forms either contain or are readily hydrolyzed in the gut to boric acid. Boric acid is reactive, and tends to accumulate in tissues other than bone or joint.
- the amount of boron made available by known supplementation is extremely high compared with normal blood values.
- a typical boron supplement, for example, may make almost 3 mg of elemental boron available to the tissues within a half hour after ingestion, which is about 14 times the normal total blood boron of 213 ⁇ g. (Hunt, CD., et al., "RDA Workshop: New Approaches, Endpoints and Paradigms for RDAs of Mineral Elements", American Institute of Nutrition, 1996, pp 2441 S - 245 IS).
- complexes of boron with sugars and/or sugar alcohols are utilized as nutritional supplements, with the carbohydrate portion being selected to provide a boron-sugar association constant of at least 250, and preferably 500 or more.
- boron is complexed with a saccharide having co- planar cis-OH groups capable of forming five or six membered rings through ester bonding with boric acid.
- Such complexes may advantageously comprise fructose, mannose, xylose or sorbose.
- the boron supplement can be included in a food.
- a food Essentially the entire gamut of foods are contemplated, including both solid and liquid foods, staples and snacks, and highly processed and minimally processed foods.
- Particularly preferred foods are magnesium containing foods, and especially magnesium containing snack foods such as those containing chocolate and/or nuts.
- Figure 1 is a schematic showing three contemplated structures I, II and III according to one aspect of the present invention, wherein Me n+ comprises a metal ion having a valence of n+.
- the present invention contemplates the use of sugar-boron complexes as nutritional supplements. Since boron may be best handled by the body in small doses spread throughout the day, it is preferred that such boron supplements would be included in foods, and especially in foods such as snacks which may be consumed throughout the day. While not limiting the class to particular types of snacks, it is contemplated that boron supplements according to the present invention may be included in solid snacks such as candies, cookies, crackers and chips, and also in beverages including soft drinks, juices, milk, liquor, beer wine and other spirits. Liquids in general may, in fact, be particularly desirable carriers for boron supplements because they may facilitate distribution of the supplement.
- boron supplements according to the present invention may advantageously be included in staple foods such as cereals or rice, and other foods such as pet foods, TV dinners and so forth.
- staple foods such as cereals or rice
- other foods such as pet foods, TV dinners and so forth.
- the term "included in” is intended to broadly encompass situations in which the boron supplement is added to the food before, during or after other processing, and where the supplement is added using whatever means is available.
- preferred boron supplemented foods may also contain relatively high amounts of magnesium.
- Particularly high magnesium containing foods are nuts, especially almonds (over 350 mg oz), and chocolate (over 80 mg/oz.).
- sugar-boron supplements may advantageously be added to chocolate and chocolate nut bars, chocolate syrups, and so-called "breakfast bars” or “snack bars” at up to 3 mg of boron per serving.
- Other preferred foods are those containing at least 25 mg/oz of magnesium, and more preferably at least 50 mg/oz of magnesium.
- the D-Glucose can be almost completely regenerated from the mother liquor.
- the crystalline fructose complex may then be purified further by recrystalization, or by other suitable means.
- the final product will be present as an equilibrium of several different forms. It is contemplated, for example, that a fructoborate such as calcium fructoborate will be present in at least the three forms depicted in Figure 1, with the equilibrium concentration of II being much greater than III, which in turn is greater than I.
- the solvent may comprise water, ethanol, acetone or any other appropriate, and preferably amphiphilic solvent.
- the starting sugar mixture may comprise any sugar or combination of sugars. Suitable sugars for the reaction thus include mono- di-, tri-, oligo- or poly-saccharides, and may range from small three carbon sugars to the larger pentoses, hexoses and so forth. It is still further contemplated that calcium carbonate can be replaced or supplemented with another metal carbonates, such as Mg carbonate.
- boric acid compounds of sorbose, sorbulose, sorbitol, and xylose, xylulose, and xylitol are all contemplated
- one or both forms may be suitable, depending upon the sugar.
- the distinction is somewhat moot in any event, because one form or the other greatly predominates in any solution.
- the boron contemplated to be used herein may predominantly comprise any mixture of the two naturally occurring forms of boron, namely 10 B and ' ⁇ . In nature, these elements are present in about a 4: 1 ratio, and it is contemplated that the ratio of boron in preferred supplements herein will have substantially the same ratio.
- sugar acids such as gluconic acid would not be particularly suitable because of their unfavorable configurations and consequently low association constants.
- sugar acids such as gluconic acid
- sucrose and “sugar alcohols” are contemplated herein to exclude sugar acids. These terms also exclude amino acids and other polyhydroxy acids such as citric acid and malic acid.
- sugar-boron compounds may be included in pharmaceutical preparations either as an active ingredient or an adjunct.
- Such preparations may be administered in any acceptable route, including per os, sublingually, by injection or intravenous infusion, nasally, by suppository, transcutaneously, and so forth, with suitable excipients, binders, carriers and other compounds included as known in the pharmaceutical arts. Dosage of such preparations is contemplated to provide between about 0.01 mg day/dose to about 10 mg/day/dose or more of boron.
- acetone (99%, p. a. quality; 20 ml) is added to the reaction mixture, whereupon a colorless oil separates at the bottom of the reaction vessel.
- Two layers are separated using a separatory funnel, and the lower layer (crude boron complex) is treated again with acetone (20 MI).
- the mixture is triturated using a glass rod to induce crystallization, and the oil slowly solidifies. This produces a white crystalline solid.
- the solid is filtered off on a Buchner funnel, washed with additional acetone, and air dried. The solid is then further dried in a vacuum oven at room temperature, leaving a solvent free, very pure Ca- fructoborate.
- the yield is 2.05 g (75%).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seeds, Soups, And Other Foods (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP54182798A JP2001518882A (ja) | 1997-03-31 | 1998-03-26 | ホウ素炭水化物錯体及びこれらの使用 |
| DE69811508T DE69811508T2 (de) | 1997-03-31 | 1998-03-26 | Bor-kohlenhydrat-komplexe und deren verwendungen |
| EP98913189A EP1001788B1 (en) | 1997-03-31 | 1998-03-26 | Boron carbohydrate complexes and uses thereof |
| AU67800/98A AU6780098A (en) | 1997-03-31 | 1998-03-26 | Boron carbohydrate complexes and uses thereof |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4288397P | 1997-03-31 | 1997-03-31 | |
| US60/042,883 | 1997-03-31 | ||
| US09/045,141 US5962049A (en) | 1997-03-31 | 1998-03-20 | Boron carbohydrate complexes and uses thereof |
| US09/045,141 | 1998-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1998043652A1 true WO1998043652A1 (en) | 1998-10-08 |
Family
ID=26719729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/006050 Ceased WO1998043652A1 (en) | 1997-03-31 | 1998-03-26 | Boron carbohydrate complexes and uses thereof |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5962049A (cg-RX-API-DMAC10.html) |
| EP (1) | EP1001788B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2001518882A (cg-RX-API-DMAC10.html) |
| AU (1) | AU6780098A (cg-RX-API-DMAC10.html) |
| DE (1) | DE69811508T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2191291T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998043652A1 (cg-RX-API-DMAC10.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005509661A (ja) * | 2001-11-20 | 2005-04-14 | ザ プロクター アンド ギャンブル カンパニー | 規定のホウ素化合物を含む組成物及びキット、それらの調製方法、並びにそれらの使用及び投与 |
| LU92551B1 (fr) * | 2014-08-29 | 2016-03-01 | Vdf Futureceuticals Inc | Compositions et procédés améliorés pour complexes de borocarbohydrate |
| EP2990058A1 (en) | 2014-08-29 | 2016-03-02 | VDF Futureceuticals, Inc. | Improved compositions and methods for fructoborate complexes |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001026665A1 (en) * | 1999-10-15 | 2001-04-19 | Bawa Rajan S | Liquid nutritional supplement composition and method of preparation |
| EP1233772A4 (en) * | 1999-11-19 | 2004-06-16 | Topgene Inc | Boron compounds and complexes as anti-inflammatories |
| US20020077354A1 (en) * | 2000-10-05 | 2002-06-20 | Dusan Miljkovic | Methods and compositions for stabilizing oxidizable compounds |
| CA2435146C (en) | 2001-01-25 | 2011-03-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Formulation of boronic acid compounds |
| US20050032743A1 (en) * | 2002-08-27 | 2005-02-10 | Dusan Miljkovic | Compositions and method for steroid homeostasis |
| US8685438B2 (en) * | 2004-03-17 | 2014-04-01 | The Iams Company | Compositions, kits, and methods utilizing an added boron source |
| CN101232821B (zh) * | 2005-06-02 | 2013-01-23 | 美国硼砂公司 | 动物和人的骨软骨病的预防和治疗 |
| NZ578133A (en) * | 2006-12-06 | 2012-08-31 | Tera Corp B | Animal feed compositions comprising supplemental boron and supplemental vitamin c |
| US8809284B2 (en) | 2009-04-03 | 2014-08-19 | Vdf Futureceuticals, Inc. | Compositions and methods related to calcitriol |
| WO2012038985A2 (en) * | 2010-09-23 | 2012-03-29 | Tata Global Beverages Limited | Trivalent chromium and boron fortifying composition, a hydration supplement, and process for preparing the same |
| US9327025B2 (en) * | 2012-10-11 | 2016-05-03 | Hanif Kazerooni | Enriched 10-boron composition for cancer therapy and a method of synthesizing the same |
| JP6438689B2 (ja) * | 2014-06-26 | 2018-12-19 | 雪印種苗株式会社 | ホウ素供給用組成物 |
| US20240325418A1 (en) | 2021-10-24 | 2024-10-03 | P.L. Thomas & Co., Inc. | Borate complexes of chlorogenic acid and uses thereof |
| CN117466966A (zh) * | 2023-10-31 | 2024-01-30 | 南通励成生物工程有限公司 | 一种果糖硼酸钙的制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554020A (en) * | 1984-03-29 | 1985-11-19 | W. R. Grace & Co. | Hydraulic cement admixture compositions |
| US4849220A (en) * | 1988-04-20 | 1989-07-18 | The United States Of America As Represented By The Secretary Of Agriculture | Use of boron supplements to increase in vivo production of hydroxylated steroids |
| US5312816A (en) * | 1991-09-13 | 1994-05-17 | Boron Biologicals, Inc. | Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
| US5659027A (en) * | 1989-12-20 | 1997-08-19 | University Of North Carolina | Boronated compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821196A (en) * | 1972-05-23 | 1974-06-28 | Us Agriculture | Carbohydrate-boron alkoxide compounds |
| JP2002514170A (ja) * | 1996-07-30 | 2002-05-14 | エナージェティクス,インコーポレイティド | 食品補充物 |
| US5985842A (en) * | 1998-05-14 | 1999-11-16 | Miljkovic; Dusan | Boron compounds/complexes to control hair growth, and methods of use |
| US6080425A (en) * | 1998-05-26 | 2000-06-27 | Topgene, Inc. | Boron compounds and complexes as skin-rejuvenating agents |
-
1998
- 1998-03-20 US US09/045,141 patent/US5962049A/en not_active Expired - Lifetime
- 1998-03-26 EP EP98913189A patent/EP1001788B1/en not_active Expired - Lifetime
- 1998-03-26 JP JP54182798A patent/JP2001518882A/ja active Pending
- 1998-03-26 WO PCT/US1998/006050 patent/WO1998043652A1/en not_active Ceased
- 1998-03-26 ES ES98913189T patent/ES2191291T3/es not_active Expired - Lifetime
- 1998-03-26 AU AU67800/98A patent/AU6780098A/en not_active Abandoned
- 1998-03-26 DE DE69811508T patent/DE69811508T2/de not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554020A (en) * | 1984-03-29 | 1985-11-19 | W. R. Grace & Co. | Hydraulic cement admixture compositions |
| US4849220A (en) * | 1988-04-20 | 1989-07-18 | The United States Of America As Represented By The Secretary Of Agriculture | Use of boron supplements to increase in vivo production of hydroxylated steroids |
| US5659027A (en) * | 1989-12-20 | 1997-08-19 | University Of North Carolina | Boronated compounds |
| US5312816A (en) * | 1991-09-13 | 1994-05-17 | Boron Biologicals, Inc. | Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP1001788A4 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005509661A (ja) * | 2001-11-20 | 2005-04-14 | ザ プロクター アンド ギャンブル カンパニー | 規定のホウ素化合物を含む組成物及びキット、それらの調製方法、並びにそれらの使用及び投与 |
| LU92551B1 (fr) * | 2014-08-29 | 2016-03-01 | Vdf Futureceuticals Inc | Compositions et procédés améliorés pour complexes de borocarbohydrate |
| EP2990058A1 (en) | 2014-08-29 | 2016-03-02 | VDF Futureceuticals, Inc. | Improved compositions and methods for fructoborate complexes |
| KR20170095803A (ko) * | 2014-08-29 | 2017-08-23 | 브이디에프 퓨쳐슈티컬스, 인코포레이티드 | 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법 |
| EP3210628A1 (en) * | 2014-08-29 | 2017-08-30 | VDF Futureceuticals, Inc. | Improved compositions and methods for fructoborate complexes |
| CN107207536A (zh) * | 2014-08-29 | 2017-09-26 | Vdf未来制剂股份有限公司 | 用于硼碳水化合物复合物的改善的组合物和方法 |
| KR20180089580A (ko) * | 2014-08-29 | 2018-08-08 | 브이디에프 퓨쳐슈티컬스, 인코포레이티드 | 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법 |
| KR101887546B1 (ko) * | 2014-08-29 | 2018-08-10 | 브이디에프 퓨쳐슈티컬스, 인코포레이티드 | 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법 |
| KR102012293B1 (ko) * | 2014-08-29 | 2019-08-20 | 브이디에프 퓨쳐슈티컬스, 인코포레이티드 | 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법 |
| KR20190102079A (ko) * | 2014-08-29 | 2019-09-02 | 브이디에프 퓨쳐슈티컬스, 인코포레이티드 | 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법 |
| KR102209337B1 (ko) | 2014-08-29 | 2021-01-28 | 브이디에프 퓨쳐슈티컬스, 인코포레이티드 | 붕소 탄수화물 복합체들에 대한 개선된 조성물 및 방법 |
| US11160819B2 (en) | 2014-08-29 | 2021-11-02 | Vdf Futureceuticals, Inc. | Compositions and methods for borocarbohydrate complexes |
| CN107207536B (zh) * | 2014-08-29 | 2022-03-01 | Vdf未来制剂股份有限公司 | 用于硼碳水化合物复合物的改善的组合物和方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU6780098A (en) | 1998-10-22 |
| DE69811508D1 (de) | 2003-03-27 |
| ES2191291T3 (es) | 2003-09-01 |
| EP1001788A4 (en) | 2000-11-29 |
| US5962049A (en) | 1999-10-05 |
| JP2001518882A (ja) | 2001-10-16 |
| EP1001788A1 (en) | 2000-05-24 |
| DE69811508T2 (de) | 2003-12-11 |
| EP1001788B1 (en) | 2003-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1001788B1 (en) | Boron carbohydrate complexes and uses thereof | |
| EP2156751B1 (en) | Novel sweetener having sugar-like taste and production method and use of the same | |
| JP5715046B2 (ja) | 目的とするヘキソースを所定量含む原料糖とは異なる糖組成の糖組成物の製造方法および製造された糖組成物の用途 | |
| EP1112693B1 (en) | Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption | |
| RU2156087C1 (ru) | Биологически активная добавка | |
| KR101007790B1 (ko) | 트레할로오스 또는 말티톨과 금속 이온 화합물과의 회합물(會合物) | |
| EP2992887B1 (en) | Agent for accelerating the energy expenditure and/or for improving the diminished energy expenditure functionality | |
| EP2754444B1 (en) | Composition for improving in vivo metabolism parameter | |
| JPWO1997047209A1 (ja) | 脂質代謝改善剤 | |
| KR0156539B1 (ko) | 4지-o-알파-디이-글루코피라노실 루틴 및 그 제조 방법 | |
| CS195704B2 (en) | Method of making the diet food mixture | |
| WO2006003107A1 (de) | Verwendung von äpfelsäureglucosiden als geschmacksstoffe | |
| JPH06500552A (ja) | カルシウム及び微量ミネラル補給品 | |
| JP2983503B2 (ja) | 高い生物学的利用能をもつ鉄‐カルシウムミネラル補給物 | |
| KR20120091398A (ko) | 콜라겐 산생 증강제와 그 제조 방법 및 용도 | |
| KR19990076491A (ko) | 글리코실-엘-아스코르브산의 아실화 유도체 | |
| JP2002338473A (ja) | 抗疲労組成物 | |
| EP3569070A1 (en) | Capsule containing pyrroloquinoline quinone or salt thereof and branched chain amino acid | |
| AU2002358347B2 (en) | Modified methionine rich food products and process for their manufacture | |
| JPH1128069A (ja) | 栄養補給飲食品 | |
| CA2431883A1 (en) | Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof | |
| US11970435B2 (en) | Taste-modified creatine salts, compounds, compositions and uses thereof | |
| RU2183408C1 (ru) | Конфета | |
| JP7287677B2 (ja) | 経口組成物及び飲食品のミネラル強化剤 | |
| KR102405534B1 (ko) | 초정수압 처리에 의한 생선의 리페이즈 억제 및 비린내 억제 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 541827 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1998913189 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1998913189 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1998913189 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1998913189 Country of ref document: EP |